Doping control in sports - A perspective from the 1996 Olympic Games

被引:4
作者
Ambrose, PJ
机构
[1] UNIV CALIF SAN FRANCISCO, SAN FRANCISCO, CA 94143 USA
[2] UNIV SO CALIF, LOS ANGELES, CA 90089 USA
[3] NATL COLLEGIATE ATHLET ASSOC, DRUG TESTING PROGRAM, OVERLAND PK, KS 66211 USA
关键词
athletes; drug abuse; education; International Olympic Committee; patient information; pharmacists; regulations; sports; tests; laboratory; toxicity;
D O I
10.1093/ajhp/54.9.1053
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Doping-control (DC) procedures, particularly as used at the 1996 Olympic Games, ate described, and the role of pharmacists in DC is discussed. DC procedures must be strict and precisely followed to avoid contamination of samples, the appearance of bias, and breaches in security and confidentiality. The proc ess of selecting athletes for testing can be random, nonrandom, or a combination of the two. Escorts are used to notify athletes of their selection, verify their identity, and accompany them to the DC station. When urine specimens are obtained for DC, the voiding process must be directly observed. The specimen is checked for pH and specific gravity and then processed for shipping to a laboratory to be analyzed for banned substances. Medication histories are also obtained, giving athletes the opportunity to declare any substance that has been taken for legitimate medical purposes. Laboratory analysis involves screening and confirmation phases. During the Atlanta Games, roughly 50 pharmacists participated in the DC program as escorts or technical officers. It is logical to involve pharmacists in DC programs because they can develop and conduct drug-testing protocols; educate athletes, coaches, and trainers about drug use and abuse; and help ensure the safe and effective use of medications. Sophisticated doping-control procedures have been developed for athletic competitions, and pharmacists have much to offer DC programs.
引用
收藏
页码:1053 / 1057
页数:5
相关论文
共 13 条
[1]   RHYTHMIC URINARY EXCRETION OF AMPHETAMINE IN MAN [J].
BECKETT, AH ;
ROWLAND, M .
NATURE, 1964, 204 (496) :1203-&
[2]  
Boje O., 1939, B HLTH ORG LEAGUE NA, V8, P439
[3]  
Catlin D H, 1991, Adv Intern Med, V36, P399
[4]   KINETICS OF COCAINE DISTRIBUTION, ELIMINATION, AND CHRONOTROPIC EFFECTS [J].
CHOW, MJ ;
AMBRE, JJ ;
RUO, TI ;
ATKINSON, AJ ;
BOWSHER, DJ ;
FISCHMAN, MW .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (03) :318-324
[5]  
FUENTES RJ, 1996, ATHLETIC DRUG REFERE
[6]  
Gordon Burgess, 1935, Ann Med Hist, V7, P513
[7]  
HENDEE WR, 1987, JAMA-J AM MED ASSOC, V257, P3110
[8]  
Kuschell J, 1996, DRUG TOPICS, V140, P12
[9]  
Laster-Bradley M, 1993, SPORTS MED STAND MAL, V5, P6
[10]   TESTING FOR DRUG-USE .1. ANALYTICAL METHODS [J].
MONTAGNE, M ;
PUGH, CB ;
FINK, JL .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1988, 45 (06) :1297-1305